par Biganzoli, Laura
;Cufer, T;Bruning, Peter;Coleman, R;Duchateau, L;Rapoport, Benjamin;Nooij, Marianne;Delhaye, François
;Miles, David J C;Sulkes, Aaron;Hamilton, Andrew;Piccart-Gebhart, Martine 
Référence Cancer, 97, 1, page (40-45)
Publication Publié, 2003-01
;Cufer, T;Bruning, Peter;Coleman, R;Duchateau, L;Rapoport, Benjamin;Nooij, Marianne;Delhaye, François
;Miles, David J C;Sulkes, Aaron;Hamilton, Andrew;Piccart-Gebhart, Martine 
Référence Cancer, 97, 1, page (40-45)
Publication Publié, 2003-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Biganzoli, Laura; Cufer, T; Bruning, Peter; Coleman, R; Duchateau, L; Rapoport, Benjamin; Nooij, Marianne; Delhaye, François; Miles, David J C; Sulkes, Aaron; Hamilton, Andrew; Piccart-Gebhart, Martine |
| Informations sur la publication: | Cancer, 97, 1, page (40-45) |
| Statut de publication: | Publié, 2003-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Cardiac toxicity |
| Doxorubicin | |
| Multicenter trials | |
| Paclitaxel | |
| MeSH keywords: | Adenocarcinoma -- drug therapy |
| Adenocarcinoma -- secondary | |
| Adult | |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- pathology | |
| Cyclophosphamide -- administration & dosage | |
| Disease Progression | |
| Disease-Free Survival | |
| Doxorubicin -- administration & dosage | |
| Female | |
| Follow-Up Studies | |
| Heart -- drug effects | |
| Humans | |
| Middle Aged | |
| Paclitaxel -- administration & dosage | |
| Risk Factors | |
| Safety | |
| Survival Rate | |
| Treatment Outcome | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase III | |
| Comparative Study | |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Research Support, Non-U.S. Gov't | |
| FLWIN | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0008-543X |
| info:doi/10.1002/cncr.10914 | |
| info:scp/0037216170 | |
| info:pmid/12491503 |



